Hakim Anat 4

What Happened

• Hakim Anat, Executive Vice President, General Counsel & Secretary of Eli Lilly, received an award/acquisition of 8,277.919 shares on 2026-02-09. The reported price per share for the acquisition is $1,044.67, for a total value of approximately $8,647,694. This filing reports an award/grant (transaction code A), not a sale.

Key Details

• Transaction date and price: 2026-02-09 at $1,044.67 per share.
• Shares awarded: 8,277.919; reported total value ≈ $8,647,694.
• Shares owned after transaction: not specified in the provided excerpt of the filing.
• Footnote: F1 — "The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein."
• Filing date: 2026-02-11. This appears to be within the standard two-business-day Form 4 filing window (not flagged as late).

Context

• This transaction is a company award/grant to an executive (common as part of compensation); awards are acquisitions of stock but do not necessarily indicate personal buying/selling intent.
• Transaction code A indicates an award/grant/acquisition rather than an open-market purchase or sale. The footnote clarifies the reporting person disclaims beneficial ownership except for any pecuniary interest.